Health Dictionary Find a Doctor

Lactose intolerance


For Patient Information, Click here.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mahda Alihashemi M.D. [2]

Synonyms and keywords: Hypolactasia, Milk intolerance, Disaccharidase deficiency, Dairy product intolerance, Diarrhea – lactose intolerance, Bloating – lactose intolerance.

Overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Mahda Alihashemi M.D. [2] [3] [4] [5] [6]

Overview

Lactose intolerance is the term used to describe a decline in the level of lactase, an enzyme needed for proper metabolization of lactose (a sugar that is a constituent of milk and other dairy products), in human beings.

Historical Perspective

Lactose intolerance first discovered by Hippocrate, ancient Greek physician 2500 years ago. In 1906, Pimmer discovered lactase enzyme in the intestine of infant dogs, pigs, and rats. The association between ethnic and lactose intolerance was discovered in 1966 by Bayless and Rosensweig. In1978, breath hydrogen test was used by Levitt, to diagnose lactose intolerance.

Classification

There is no established system for the classification of lactose intolerance. Lactose intolerance may be classified according to its causes into 2 groups: primary lactose malabsorption and secondary lactose malabsorption. Primary lactose malabsorption may be classified into 3 subtypes: acquired primary lactase deficiency, congenital lactase deficiency and developmental lactase deficiency. Secondary lactose malabsorption occurs as a result of the underlying intestinal diseases such as small intestinal bacterial overgrowthsmall intestinal infection such as giardiasis and small intestinalinflammation.

Pathophysiology

It is thought that lactose intolerance is the result of lactose malabsorption that it is caused by low level of small intestinal lactase. Lactose is metabolized by intestinal lactase to galactose and glucose in villous enterocytes. In colon, unabsorbed lactose is converted to hydrogen gas and short chain fatty acids such as acetate, butyrate and propionate by intestinal bacteria and creates symtoms of lactose intolerance. Lactose intolerance is transmitted in an autosomal recessive pattern. Acquired primary lactase deficiency is associated with a CC genotype at -13.9 kb upstream of the lactase gene. On gross and microscopic pathology, there are no characteristic findings of lactose intolerance.

Causes

The most common cause of lactose intolerance is acquired primary lactase deficiency. Less common causes of lactose intolerance include Small intestinal bacterial overgrowthInfections such as giardiasisDrug induced enteritis, Celiac sprueTropical sprueWhipple’s disease.

Differentiating Lactose Intolerance from other Diseases

The differential diagnosis must distinguish lactose intolerance from milk allergy, which is an abnormal immune response (usually) to milk proteins.

Epidemiology and Demographics

The prevalence of lactose intolerance is approximately 75000 per 100,000 individuals worldwide. The prevalence of lactose intolerance is low in children younger than six years. Europeans and European Americans individuals are less likely to develop lactose intolerance. Lactose intolerance affects men and women equally. The majority of lactose intolerance cases are reported in the Far East

Risk Factors

The most potent risk factor in the development of lactose intolerance is ethnicity. Other risk factors include increasing age, infection and drug.

Screening

There is insufficient evidence to recommend routine screening for lactose intolerance.

Natural History, Complications and Prognosis

If left untreated, patients with lactose intoelrance may progress to develop malnutrition, osteomalacia , and osteopenia. Common complications of lactose intoelrance include if they do not intake calcium include osteoprosis, osteopenia, osteomalacia and malnutrition. Prognosis is generally excellent.

Diagnosis

Diagnostic study of choice

Small bowel biopsy such as jejunal or duodenal biopsy is the gold standard test for the diagnosis of lactose intolerance. Low lactase activity in small bowel biopsy is confirmatory of lactose intolerance.The diagnostic study of choice for lactose intolerance is lactose breath hydrogen test. Lactose intolerance is diagnosed based on a rise in hydrogen concentration of 20 ppm ( parts per million) and presentation of symptoms such as bloating, diarrhea and abdominal pain.

History and Symptoms

A positive history of abdominal pain and bloating after ingestion of milk-containing products is suggestive of lactose intolerance. Common symptoms of lactose intolerance include abdominal pain, bloating and flatulence. Less common symptoms of lactose intolerance include nausea, vomiting, and watery diarrhea.

Physical Examination

Physical examination findings are usually normal. Borborygmi may be audible.

Laboratory Findings

Laboratory tests include hydrogen breath test, stool acidity test, and intestinal biopsy. Since lactose intolerance is the normal state for most adults on a worldwide scale, and not considered a disease condition, diagnosis is not necessarily required.

Electrocardiogram

There are no ECG findings associated with lactose intolerance.

Chest X Ray

There are no x-ray findings associated with lactose intolerance.

CT

There are no CT scan findings associated with lactose intolerance.

MRI

There are no MRI findings associated with lactose intolerance.

Echocardiography or Ultrasound

There are no echocardiography/ ultrasound findings associated with lactose intolerance.

Other Imaging Findings

There are no other imaging findings associated with lactose intolerance.

Other Diagnostic Studies

Lactose intolerance test may be helpful in the diagnosis of lactose intolerance. Findings suggestive of lactose intolerance include bloatingdiarrhea and abdominal pain and rising of blood glucose by less than 20 mg/dL after ingestion of lactose. Genetic test can also be used for diagnosis of primary lactase deficiency that is associated with CC genotype at -13.9 kb upstream of the lactase gene.

Treatment

Medical Therapy

The mainstay of treatment for lactose intolerance is lifestyle modification that includes reducing dairy products from the diet and taking lactose-free or reduced lactose dairy products. Pharmacologic medical therapies for lactose intolerance include lactase enzyme preparations such as lactaid, lactogest, dairyease.

Surgery

Surgical intervention is not recommended for the management of lactose intolerance.

Primary Prevention

There are no established measures for the primary prevention of lactose intolerance.

Secondary Prevention

Effective measures for the secondary prevention of lactose intolerance include reducing dairy products from the diet, taking lactose-free or reduced lactose dairy products and ingestion of lactaseenzyme tablets before eating the dairy product.

References

Template:WS Template:WH

Historical Perspective


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mahda Alihashemi M.D. [2]

Overview

Lactose intolerance was first discovered by Hippocrate, the ancient Greek physician 2500 years ago. In 1906, Pimmer discovered lactase enzyme in the intestine of infant dogs, pigs, and rats. The association between the ethnicity and lactose intolerance was discovered in 1966 by Bayless and Rosensweig. In 1978, breath hydrogen test was used by Levitt to diagnose lactose intolerance.

Historical Perspective

Discovery

  • Lactose intolerance was first discovered by Hippocrate, the ancient Greek physician 2500 years ago.[1]
  • In 1906, Pimmer was the first scientist to discover lactase enzyme in the intestine of infant dogs, pigs, and rats. He also found that this enzyme decreased in the adult intestine of these animals.[1]
  • In 1959, Durand and Holzei et al decribed congenital lactase deficiency[1]
  • The association between the ethnicity and lactose intolerance was discovered in 1966 by Bayless and Rosensweig and in 1968 by Neale.
  • In the early 1970s, lactase-phlorizin hydrolase (LPH) gene mutations were first implicated in the pathogenesis of lactose intolerance.[2]
  • In 1978, breath hydrogen test was used by Levitt to diagnose lactose intolerance[3]


References

  1. 1.0 1.1 1.2 Neale G (1973). “The geographical incidence of lactase deficiency”. Pathol Microbiol (Basel). 39 (3): 238–47. PMID 4718561.
  2. Enattah NS, Sahi T, Savilahti E, Terwilliger JD, Peltonen L, Järvelä I (2002). “Identification of a variant associated with adult-type hypolactasia”. Nat. Genet. 30 (2): 233–7. doi:10.1038/ng826. PMID 11788828.
  3. Rana SV, Malik A (2014). “Hydrogen breath tests in gastrointestinal diseases”. Indian J Clin Biochem. 29 (4): 398–405. doi:10.1007/s12291-014-0426-4. PMC 4175689. PMID 25298621.

Template:WH

Classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mahda Alihashemi M.D. [2]

Overview

There is no established system for the classification of lactose intolerance. Lactose intolerance may be classified according to its causes into 2 groups: primary lactose malabsorption and secondary lactose malabsorption. Primary lactose malabsorption may be classified into 3 subtypes: acquired primary lactase deficiency, congenital lactase deficiency and developmental lactase deficiency. Secondary lactose malabsorption occurs as a result of the underlying intestinal diseases such as small intestinal bacterial overgrowth, small intestinal infection such as giardiasis and small intestinal inflammation.

Classification


 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
lactose intolerance
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Primary lactose malabsorption
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Secondary lactose malabsorption
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Acquired primary lactase deficiency
 
Congenital lactase deficiency
 
Developmental lactase deficiency
 
 
 
 
 
 
 
 
 
 
Small intestinal bacterial overgrowth
 
Small intestinal infection
 
 
Small intestinal inflammation


  • There is no established system for the classification of lactose intolerance.
  • Lactose intolerance can be classified according to its causes into 2 groups:
    • Primary lactose malabsorption 
    • Secondary lactose malabsorption
  • Primary lactose malabsorption can be classified into 3 subtypes:
    • Acquired primary lactase deficiency 
    • Congenital lactase deficiency
    • Developmental lactase deficiency

Primary lactose intolerance

Acquired primary lactase deficiency ( lactase nonpersistence, adult-type hypolactasia)

  • The most common cause of primary lactase malabsorbtion.
  • In this type of disease, environmental and genetic factors collaborate with each other to develop lactose intolerance.
  • Autosomal recessive trait.[1]
  • Intestinal lactase levels are decreased at preschool age in many populations especially in Asia and Africa.
  • Elevated lactase activity is maintained in Caucasians such as Northern European.
  • Convergent evolution of lactase persistence is seen in some populations in Africa that domesticate cows and consume milk product into adulthood. [2]
  • Persistence of intestinal lactase until adulthood is inherited in an autosomal dominant manner.[3]

Congenital lactase deficiency

Developmental lactase deficiency

  • Low lactase levels in premature infants that were born at 28 to 32 weeks of gestation[6] 
  • Clinical lactose intolerance is uncommon because colonic flora ferment lactose to hydrogen and short chain fatty acids and then fatty acids are absorbed by the colon.

Secondary lactose malabsorption

Secondary lactose malabsorption occurs as a result of the underlying intestinal diseases such as:[7]

References

  1. Enattah NS, Sahi T, Savilahti E, Terwilliger JD, Peltonen L, Järvelä I (2002). “Identification of a variant associated with adult-type hypolactasia”. Nat. Genet. 30 (2): 233–7. doi:10.1038/ng826. PMID 11788828.
  2. Tishkoff SA, Reed FA, Ranciaro A, Voight BF, Babbitt CC, Silverman JS, Powell K, Mortensen HM, Hirbo JB, Osman M, Ibrahim M, Omar SA, Lema G, Nyambo TB, Ghori J, Bumpstead S, Pritchard JK, Wray GA, Deloukas P (2007). “Convergent adaptation of human lactase persistence in Africa and Europe”. Nat. Genet. 39 (1): 31–40. doi:10.1038/ng1946. PMC 2672153. PMID 17159977.
  3. Scrimshaw NS, Murray EB (1988). “The acceptability of milk and milk products in populations with a high prevalence of lactose intolerance”. Am. J. Clin. Nutr. 48 (4 Suppl): 1079–159. PMID 3140651.
  4. Saarela T, Similä S, Koivisto M (1995). “Hypercalcemia and nephrocalcinosis in patients with congenital lactase deficiency”. J. Pediatr. 127 (6): 920–3. PMID 8523189.
  5. Kuokkanen M, Kokkonen J, Enattah NS, Ylisaukko-Oja T, Komu H, Varilo T, Peltonen L, Savilahti E, Jarvela I (2006). “Mutations in the translated region of the lactase gene (LCT) underlie congenital lactase deficiency”. Am. J. Hum. Genet. 78 (2): 339–44. doi:10.1086/500053. PMC 1380240. PMID 16400612.
  6. Mobassaleh M, Montgomery RK, Biller JA, Grand RJ (1985). “Development of carbohydrate absorption in the fetus and neonate”. Pediatrics. 75 (1 Pt 2): 160–6. PMID 2578223.
  7. Srinivasan R, Minocha A (1998). “When to suspect lactose intolerance. Symptomatic, ethnic, and laboratory clues”. Postgrad Med. 104 (3): 109–11, 115–6, 122–3. doi:10.3810/pgm.1998.09.577. PMID 9742907.
  8. Misselwitz B, Pohl D, Frühauf H, Fried M, Vavricka SR, Fox M (2013). “Lactose malabsorption and intolerance: pathogenesis, diagnosis and treatment”. United European Gastroenterol J. 1 (3): 151–9. doi:10.1177/2050640613484463. PMC 4040760. PMID 24917953.
  9. Swagerty DL, Walling AD, Klein RM (2002). “Lactose intolerance”. Am Fam Physician. 65 (9): 1845–50. PMID 12018807.
  10. Mishkin B, Yalovsky M, Mishkin S (1997). “Increased prevalence of lactose malabsorption in Crohn’s disease patients at low risk for lactose malabsorption based on ethnic origin”. Am. J. Gastroenterol. 92 (7): 1148–53. PMID 9219788.
  11. Kirschner BS, DeFavaro MV, Jensen W (1981). “Lactose malabsorption in children and adolescents with inflammatory bowel disease”. Gastroenterology. 81 (5): 829–32. PMID 6895202.

Template:WH Template:WS

Pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mahda Alihashemi M.D. [2]

Overview

It is thought that lactose intolerance is the result of lactose malabsorption caused by low levels of small intestinal lactase. Lactose is metabolized by the intestinal lactase to galactose and glucose in villous enterocytes. In the colon, unabsorbed lactose is converted to hydrogen and short chain fatty acids such as acetate, butyrate and propionate by intestinal bacteria and creates symtoms of lactose intolerance. Lactose intolerance is inherited in an autosomal recessive pattern. Acquired primary lactase deficiency is associated with a CC genotype at -13.9 kb upstream of the lactase gene. On gross and microscopic pathology, there are no characteristic findings of lactose intolerance.

Pathophysiology

Pathogenesis

Genetics

  • Lactose intolerance is transmitted in an autosomal recessive pattern.[5]
  • Persistence of intestinal lactase until adulthood is inherited as an autosomal dominant manner.[6]
  • Genes involved in the pathogenesis of lactose intolerance include polymorphism of the MCM6 ( minichromosome maintenance complex component 6), gene located upstream from the gene lactase-phlorizin hydrolase (LPH) on the long arm (q) of chromosome 2 in region 21 (2q21). Lactase persistence is strongly related with the presence of the T allele of the single nucleotide polymorphisms (SNP ) located at -13.9 kb upstream of the lactase gene. This allele regulates lactase mRNA.[7][8]
  • Acquired primary lactase deficiency is associated with a CC genotype at -13.9 kb and lactase persistence is related to TT genotype.[9]

Gross Pathology

  • On gross pathology, there are no characteristic findings for lactose intolerance.

Microscopic Pathology

  • On microscopic histopathological analysis, there are no characteristic findings for lactose intolerance.

References

  1. Silanikove N, Leitner G, Merin U (2015). “The Interrelationships between Lactose Intolerance and the Modern Dairy Industry: Global Perspectives in Evolutional and Historical Backgrounds”. Nutrients. 7 (9): 7312–31. doi:10.3390/nu7095340. PMC 4586535. PMID 26404364.
  2. Maiuri L, Raia V, Potter J, Swallow D, Ho MW, Fiocca R, Finzi G, Cornaggia M, Capella C, Quaroni A (1991). “Mosaic pattern of lactase expression by villous enterocytes in human adult-type hypolactasia”. Gastroenterology. 100 (2): 359–69. PMID 1702075.
  3. Martín MG, Turk E, Lostao MP, Kerner C, Wright EM (1996). “Defects in Na+/glucose cotransporter (SGLT1) trafficking and function cause glucose-galactose malabsorption”. Nat. Genet. 12 (2): 216–20. doi:10.1038/ng0296-216. PMID 8563765.
  4. Yoshida Y, Sasaki G, Goto S, Yanagiya S, Takashina K (1975). “Studies on the etiology of milk intolerance in Japanese adults”. Gastroenterol. Jpn. 10 (1): 29–34. PMID 1234085.
  5. Enattah NS, Sahi T, Savilahti E, Terwilliger JD, Peltonen L, Järvelä I (2002). “Identification of a variant associated with adult-type hypolactasia”. Nat. Genet. 30 (2): 233–7. doi:10.1038/ng826. PMID 11788828.
  6. Scrimshaw NS, Murray EB (1988). “The acceptability of milk and milk products in populations with a high prevalence of lactose intolerance”. Am. J. Clin. Nutr. 48 (4 Suppl): 1079–159. PMID 3140651.
  7. Kuokkanen M, Enattah NS, Oksanen A, Savilahti E, Orpana A, Järvelä I (2003). “Transcriptional regulation of the lactase-phlorizin hydrolase gene by polymorphisms associated with adult-type hypolactasia”. Gut. 52 (5): 647–52. PMC 1773659. PMID 12692047.
  8. Buzás GM (2015). “[Lactose intolerance: past and present. Part 1]”. Orv Hetil (in Hungarian). 156 (38): 1532–9. doi:10.1556/650.2015.30261. PMID 26550699.
  9. Rasinperä H, Savilahti E, Enattah NS, Kuokkanen M, Tötterman N, Lindahl H, Järvelä I, Kolho KL (2004). “A genetic test which can be used to diagnose adult-type hypolactasia in children”. Gut. 53 (11): 1571–6. doi:10.1136/gut.2004.040048. PMC 1774274. PMID 15479673.

Template:WH Template:WS

Causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mahda Alihashemi M.D. [2]

Overview

The most common cause of lactose intolerance is acquired primary lactase deficiency. Less common causes of lactose intolerance include Small intestinal bacterial overgrowth, Infections such as giardiasis, Drug induced enteritis, Celiac sprue, Tropical sprue, and Whipple’s disease.

Causes

Life-threatening Causes

  • Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. There are no life-threatening causes of lactose intolerance.

Common Causes

The most common cause of lactose intolerance is

  • Acquired primary lactase deficiency (lactase nonpersistence, adult-type hypolactasia)[1][2]

Less Common Causes

Less common causes of lactose intolerance include:

Genetic Causes

  • Lactose intolerance is caused by a mutation in the lactase-phlorizin hydrolase (LPH) gene.[9][10][11]

Causes by Organ System

Cardiovascular No underlying causes
Chemical/Poisoning No underlying causes
Dental No underlying causes
Dermatologic Celiac sprue,
Drug Side Effect Drug induced enteritis,
Ear Nose Throat No underlying causes
Endocrine Carcinoid syndrome, Diabetic gastropathy, Kwashiorkor, Zollinger-Ellison syndrome
Environmental No underlying causes
Gastroenterologic Acquired primary lactase deficiency, Small intestinal bacterial overgrowth, Drug induced enteritis, Radiation induced enteritis, HIV enteropathy, Tropical sprue, Celiac sprue, Whipple’s disease, Gastroenteritis, Carcinoid syndrome, Cystic fibrosis, Diabetic gastropathy,

Kwashiorkor, Zollinger-Ellison syndrome

Genetic Celiac sprue, lactase-phlorizin hydrolase (LPH) gene mutation
Hematologic No underlying causes
Iatrogenic Radiation induced enteritis, Chemotherapy 
Infectious Disease Infections such as giardiasis, HIV enteropathy, Tropical sprue, Whipple’s disease,
Musculoskeletal/Orthopedic No underlying causes
Neurologic No underlying causes
Nutritional/Metabolic Celiac sprue, Cystic fibrosis,
Obstetric/Gynecologic No underlying causes
Oncologic Carcinoid syndrome, Zollinger-Ellison syndrome,
Ophthalmologic No underlying causes
Overdose/Toxicity No underlying causes
Psychiatric No underlying causes
Pulmonary Cystic fibrosis,
Renal/Electrolyte No underlying causes
Rheumatology/Immunology/Allergy Celiac sprue
Sexual No underlying causes
Trauma No underlying causes
Urologic No underlying causes
Miscellaneous No underlying causes

Causes in Alphabetical Order

List the causes of the disease in alphabetical order.

References

  1. Enattah NS, Sahi T, Savilahti E, Terwilliger JD, Peltonen L, Järvelä I (2002). “Identification of a variant associated with adult-type hypolactasia”. Nat. Genet. 30 (2): 233–7. doi:10.1038/ng826. PMID 11788828.
  2. Tishkoff SA, Reed FA, Ranciaro A, Voight BF, Babbitt CC, Silverman JS, Powell K, Mortensen HM, Hirbo JB, Osman M, Ibrahim M, Omar SA, Lema G, Nyambo TB, Ghori J, Bumpstead S, Pritchard JK, Wray GA, Deloukas P (2007). “Convergent adaptation of human lactase persistence in Africa and Europe”. Nat. Genet. 39 (1): 31–40. doi:10.1038/ng1946. PMC 2672153. PMID 17159977.
  3. Srinivasan R, Minocha A (1998). “When to suspect lactose intolerance. Symptomatic, ethnic, and laboratory clues”. Postgrad Med. 104 (3): 109–11, 115–6, 122–3. doi:10.3810/pgm.1998.09.577. PMID 9742907.
  4. Misselwitz B, Pohl D, Frühauf H, Fried M, Vavricka SR, Fox M (2013). “Lactose malabsorption and intolerance: pathogenesis, diagnosis and treatment”. United European Gastroenterol J. 1 (3): 151–9. doi:10.1177/2050640613484463. PMC 4040760. PMID 24917953.
  5. Swagerty DL, Walling AD, Klein RM (2002). “Lactose intolerance”. Am Fam Physician. 65 (9): 1845–50. PMID 12018807.
  6. Mishkin B, Yalovsky M, Mishkin S (1997). “Increased prevalence of lactose malabsorption in Crohn’s disease patients at low risk for lactose malabsorption based on ethnic origin”. Am. J. Gastroenterol. 92 (7): 1148–53. PMID 9219788.
  7. Saarela T, Similä S, Koivisto M (1995). “Hypercalcemia and nephrocalcinosis in patients with congenital lactase deficiency”. J. Pediatr. 127 (6): 920–3. PMID 8523189.
  8. Mobassaleh M, Montgomery RK, Biller JA, Grand RJ (1985). “Development of carbohydrate absorption in the fetus and neonate”. Pediatrics. 75 (1 Pt 2): 160–6. PMID 2578223.
  9. Enattah NS, Sahi T, Savilahti E, Terwilliger JD, Peltonen L, Järvelä I (2002). “Identification of a variant associated with adult-type hypolactasia”. Nat. Genet. 30 (2): 233–7. doi:10.1038/ng826. PMID 11788828.
  10. Kuokkanen M, Enattah NS, Oksanen A, Savilahti E, Orpana A, Järvelä I (2003). “Transcriptional regulation of the lactase-phlorizin hydrolase gene by polymorphisms associated with adult-type hypolactasia”. Gut. 52 (5): 647–52. PMC 1773659. PMID 12692047.
  11. Rasinperä H, Savilahti E, Enattah NS, Kuokkanen M, Tötterman N, Lindahl H, Järvelä I, Kolho KL (2004). “A genetic test which can be used to diagnose adult-type hypolactasia in children”. Gut. 53 (11): 1571–6. doi:10.1136/gut.2004.040048. PMC 1774274. PMID 15479673.

Template:WH Template:WS

Differentiating Lactose Intolerance from Other Diseases

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mahda Alihashemi M.D. [2]

Overview

Lactose intolerance must be differentiated from other diseases that cause diarrhea such as pancreatic insufficiency, irritable bowel syndrome, small intestinal bacterial overgrowth, celiac disease, and inflammatory bowel disease[1][2][3]

Differentiating lactose intolerance from other Diseases

  • Lactose intolerance must be differentiated from other diseases that cause diarrhea such as pancreatic insufficiency, irritable bowel syndrome, small intestinal bacterial overgrowth, celiac disease, and inflammatory bowel disease[1][2][3]
  • Lactose intolerance must be differentiated from other causes that produce bloating and flatulence such as beans that contain stachyose and raffinose, two indigestible sugars.[4]


References

  1. 1.0 1.1 Mattar R, de Campos Mazo DF, Carrilho FJ (2012). “Lactose intolerance: diagnosis, genetic, and clinical factors”. Clin Exp Gastroenterol. 5: 113–21. doi:10.2147/CEG.S32368. PMC 3401057. PMID 22826639.
  2. 2.0 2.1 Suchy FJ, Brannon PM, Carpenter TO, Fernandez JR, Gilsanz V, Gould JB, Hall K, Hui SL, Lupton J, Mennella J, Miller NJ, Osganian SK, Sellmeyer DE, Wolf MA (2010). “National Institutes of Health Consensus Development Conference: lactose intolerance and health”. Ann. Intern. Med. 152 (12): 792–6. doi:10.7326/0003-4819-152-12-201006150-00248. PMID 20404261.
  3. 3.0 3.1 Novillo A, Peralta D, Dima G, Besasso H, Soifer L (2010). “[Frequency of bacterial overgrowth in patients with clinical lactose intolerance]”. Acta Gastroenterol. Latinoam. (in Spanish; Castilian). 40 (3): 221–4. PMID 21053480.
  4. Suarez FL, Levitt MD (2000). “An understanding of excessive intestinal gas”. Curr Gastroenterol Rep. 2 (5): 413–9. PMID 10998670.

Template:WH Template:WS The table below summarizes the findings that differentiate watery causes of chronic diarrhea[1][2][3][4]

Cause Osmotic gap History Physical exam Gold standard Treatment
< 50 mOsm per kg > 50 mOsm per kg*
Watery Secretory Crohns +
Hyperthyroidism +
VIPoma +
  • Elevated VIP levels
  • Followed by imaging
Osmotic Lactose intolerance +
Celiac disease +
Functional Irritable bowel syndrome

Abdominal pain or discomfort recurring at least 3 days per month in the past 3 months and associated with 2 or more of the following:

  • Onset associated with change in frequency of stool
  • Onset associated with change in appearance of stool

History of straining is also common

Template:WikiDoc Sources


The table below summarizes the findings that differentiate fatty causes of chronic diarrhea[5][6][7]

Cause Osmotic gap History Physical exam Gold standard Treatment
< 50

mOsm

per kg

> 50

mOsm

per kg*

lactose intolerance + Lactose breath hydrogen test Restriction of lactose and maintain calcium and vitamin D intake.
Celiac sprue + Immunoglobulin A (IgA) anti-tissue transglutaminase (TTG) antibody followed by upper endoscopy with biopsy. Dietary counseling, elimination of gluten in the diet.
Whipple disease + Upper endoscopy with biopsies of the small intestine for T. whipplei testing (histology with PAS staining, polymerase chain reaction [[[PCR]]] testing, and immunohistochemistry) Doxycycline and hydroxychloroquine are bactericidal

Lactose intolerance must be differentiated from diseases that cause abdominal pain and chronic diarrhea. The table below summarizes the findings that differentiate watery causes of chronic diarrhea:[8][1][2][3][4]

Cause Osmotic gap History Physical exam Gold standard for diagnosis
< 50 mOsm per kg > 50 mOsm per kg*
Zollinger-Ellison syndrome + Gastrin levels
Crohn’s disease +
Hyperthyroidism +
VIPoma +
  • Elevated VIP levels
  • Followed by imaging
Lactose intolerance +
Celiac disease +
Irritable bowel syndrome

Abdominal pain or discomfort recurring at least 3 days per month in the past 3 months and associated with 2 or more of the following:

  • Onset associated with change in frequency of stool
  • Onset associated with change in appearance of stool

History of straining is also common.

References

  1. 1.0 1.1 Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR; et al. (2005). “Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology”. Can J Gastroenterol. 19 Suppl A: 5A–36A. PMID 16151544.
  2. 2.0 2.1 Sauter GH, Moussavian AC, Meyer G, Steitz HO, Parhofer KG, Jüngst D (2002). “Bowel habits and bile acid malabsorption in the months after cholecystectomy”. Am J Gastroenterol. 97 (7): 1732–5. doi:10.1111/j.1572-0241.2002.05779.x. PMID 12135027.
  3. 3.0 3.1 Maiuri L, Raia V, Potter J, Swallow D, Ho MW, Fiocca R; et al. (1991). “Mosaic pattern of lactase expression by villous enterocytes in human adult-type hypolactasia”. Gastroenterology. 100 (2): 359–69. PMID 1702075.
  4. 4.0 4.1 RUBIN CE, BRANDBORG LL, PHELPS PC, TAYLOR HC (1960). “Studies of celiac disease. I. The apparent identical and specific nature of the duodenal and proximal jejunal lesion in celiac disease and idiopathic sprue”. Gastroenterology. 38: 28–49. PMID 14439871.
  5. Hertzler SR, Savaiano DA (1996). “Colonic adaptation to daily lactose feeding in lactose maldigesters reduces lactose intolerance”. Am J Clin Nutr. 64 (2): 232–6. PMID 8694025.
  6. Briet F, Pochart P, Marteau P, Flourie B, Arrigoni E, Rambaud JC (1997). “Improved clinical tolerance to chronic lactose ingestion in subjects with lactose intolerance: a placebo effect?”. Gut. 41 (5): 632–5. PMC 1891556. PMID 9414969.
  7. BLACK-SCHAFFER B (1949). “The tinctoral demonstration of a glycoprotein in Whipple’s disease”. Proc Soc Exp Biol Med. 72 (1): 225–7. PMID 15391722.
  8. SCOBIE BA, MCGILL DB, PRIESTLEY JT, ROVELSTAD RA (1964). “EXCLUDED GASTRIC ANTRUM SIMULATING THE ZOLLINGER-ELLISON SYNDROME”. Gastroenterology. 47: 184–7. PMID 14201408.
Epidemiology and Demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mahda Alihashemi M.D. [2]

Overview

The prevalence of lactose intolerance is approximately 75,000 per 100,000 individuals worldwide. The prevalence of lactose intolerance is low in children younger than six years. Europeans and European Americans individuals are less likely to develop lactose intolerance. Lactose intolerance affects men and women equally. The majority of lactose intolerance cases are reported in the Far East.

Epidemiology and Demographics

Prevalence

  • The prevalence of lactose intolerance is up to 75000 per 100,000 individuals worldwide.[1][2]
  • In North America, the prevalence of lactose intolerance:
    • Native America: 79000 per 100,000 individuals
    • Black: 75000 per 100,000 individuals
    • Hispanics: 51000 per 100,000 individuals
    • Caucasians: 21000 per 100,000 individuals
  • The prevalence of lactose intolerance in Latin America, Africa, and Asia is 15000-100000 per 100,000 individuals.

Age

  • The prevalence of lactose intoleance is low in children younger than six years. [3][4]
  • The prevalence of lactose intoleance incereses with age.

Race

  • Lactose intolerance usually affects the following populations:[2][5]
    • African Americans
    • Hispanics
    • Asians
    • Asian Americans
    • Native Americans
  • Europeans and European Americans are less likely to develop lactose intolerance.

Gender

  • Lactose intolerance affects men and women equally.

Region

  • The majority of lactose intolerance cases are reported in the Far East.[6]
  • Northwestern Europe has the lowest prevalence of lactose intolerance.
  • The following countries have the highest rates of lactose intolerance in Africa:[7]
    • Nigeria
    • Malawi
    • Sudan
    • Ethiopia
    • Uganda
  • The following countries have the lowest rates of lactose intolerance in Africa:
    • Cameroon 
    • Mali 
    • South Africa
    • Morocco
  • Congenital lactase deficiency is a rare disease that tends to affect Finnish population.[8]

Developing Countries

  • Secondary lactase deficiency is more common in children, particularly in the the developing countries due to high prevalence of infections. [9]

References

  1. Silanikove N, Leitner G, Merin U (2015). “The Interrelationships between Lactose Intolerance and the Modern Dairy Industry: Global Perspectives in Evolutional and Historical Backgrounds”. Nutrients. 7 (9): 7312–31. doi:10.3390/nu7095340. PMC 4586535. PMID 26404364.
  2. 2.0 2.1 Scrimshaw NS, Murray EB (1988). “The acceptability of milk and milk products in populations with a high prevalence of lactose intolerance”. Am. J. Clin. Nutr. 48 (4 Suppl): 1079–159. PMID 3140651.
  3. Rao DR, Bello H, Warren AP, Brown GE (1994). “Prevalence of lactose maldigestion. Influence and interaction of age, race, and sex”. Dig. Dis. Sci. 39 (7): 1519–24. PMID 8026265.
  4. Di Stefano M, Veneto G, Malservisi S, Strocchi A, Corazza GR (2001). “Lactose malabsorption and intolerance in the elderly”. Scand. J. Gastroenterol. 36 (12): 1274–8. PMID 11761016.
  5. Itan Y, Jones BL, Ingram CJ, Swallow DM, Thomas MG (2010). “A worldwide correlation of lactase persistence phenotype and genotypes”. BMC Evol. Biol. 10: 36. doi:10.1186/1471-2148-10-36. PMC 2834688. PMID 20144208.
  6. Sahi T (1994). “Genetics and epidemiology of adult-type hypolactasia”. Scand. J. Gastroenterol. Suppl. 202: 7–20. PMID 8042019.
  7. Mattar R, de Campos Mazo DF, Carrilho FJ (2012). “Lactose intolerance: diagnosis, genetic, and clinical factors”. Clin Exp Gastroenterol. 5: 113–21. doi:10.2147/CEG.S32368. PMC 3401057. PMID 22826639.
  8. Järvelä I, Enattah NS, Kokkonen J, Varilo T, Savilahti E, Peltonen L (1998). “Assignment of the locus for congenital lactase deficiency to 2q21, in the vicinity of but separate from the lactase-phlorizin hydrolase gene”. Am. J. Hum. Genet. 63 (4): 1078–85. PMC 1377496. PMID 9758622.
  9. Bhatnagar S, Aggarwal R (2007). “Lactose intolerance”. BMJ. 334 (7608): 1331–2. doi:10.1136/bmj.39252.524375.80. PMC 1906652. PMID 17599979.

Template:WH Template:WS _

Risk Factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mahda Alihashemi M.D. [2]

Overview

The most potent risk factor in the development of lactose intolerance is ethnicity. Other risk factors include increasing age, infection and drug.

Risk Factors

The most potent risk factor in the development of lactose intolerance is ethnicity. Other risk factors include increasing age, infection and drug.

Common Risk Factors

  • Common risk factors in the development of lactose intolerance include:[1][2]
    • Increasing age: The prevalence of lactose intoleance is low in children younger than six years
    • Ethnicity: Lactose intolerance is more common in African Americans, Hispanics, Asians, Asian Americans, Native Americans

Less Common Risk Factors

References

  1. Enattah NS, Sahi T, Savilahti E, Terwilliger JD, Peltonen L, Järvelä I (2002). “Identification of a variant associated with adult-type hypolactasia”. Nat. Genet. 30 (2): 233–7. doi:10.1038/ng826. PMID 11788828.
  2. Tishkoff SA, Reed FA, Ranciaro A, Voight BF, Babbitt CC, Silverman JS, Powell K, Mortensen HM, Hirbo JB, Osman M, Ibrahim M, Omar SA, Lema G, Nyambo TB, Ghori J, Bumpstead S, Pritchard JK, Wray GA, Deloukas P (2007). “Convergent adaptation of human lactase persistence in Africa and Europe”. Nat. Genet. 39 (1): 31–40. doi:10.1038/ng1946. PMC 2672153. PMID 17159977.
  3. Srinivasan R, Minocha A (1998). “When to suspect lactose intolerance. Symptomatic, ethnic, and laboratory clues”. Postgrad Med. 104 (3): 109–11, 115–6, 122–3. doi:10.3810/pgm.1998.09.577. PMID 9742907.
  4. Misselwitz B, Pohl D, Frühauf H, Fried M, Vavricka SR, Fox M (2013). “Lactose malabsorption and intolerance: pathogenesis, diagnosis and treatment”. United European Gastroenterol J. 1 (3): 151–9. doi:10.1177/2050640613484463. PMC 4040760. PMID 24917953.
  5. Mishkin B, Yalovsky M, Mishkin S (1997). “Increased prevalence of lactose malabsorption in Crohn’s disease patients at low risk for lactose malabsorption based on ethnic origin”. Am. J. Gastroenterol. 92 (7): 1148–53. PMID 9219788.

Template:WH Template:WS

Screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mahda Alihashemi M.D. [2]

Overview

There is insufficient evidence to recommend routine screening for lactose intolerance.

Screening

 There is insufficient evidence to recommend routine screening for lactose intolerance.

References

Template:WH Template:WS

Natural History, Complications and Prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mahda Alihashemi M.D. [2]

Overview

If left untreated, patients with lactose intoelrance may progress to develop malnutrition, osteomalacia, and osteopenia. Common complications of lactose intoelrance include include osteoprosis, osteopenia, osteomalacia (especially in the absence of calcium supplements) and malnutrition. Prognosis is generally excellent.

Natural History, Complications, and Prognosis

Natural History

Complications

Prognosis

  • Prognosis is generally excellent.

References

  1. Szilagyi A (2015). “Adult lactose digestion status and effects on disease”. Can J Gastroenterol Hepatol. 29 (3): 149–56. PMC 4399375. PMID 25855879.
  2. Suarez FL, Savaiano DA, Levitt MD (1995). “A comparison of symptoms after the consumption of milk or lactose-hydrolyzed milk by people with self-reported severe lactose intolerance”. N. Engl. J. Med. 333 (1): 1–4. doi:10.1056/NEJM199507063330101. PMID 7776987.
  3. Mattar R, de Campos Mazo DF, Carrilho FJ (2012). “Lactose intolerance: diagnosis, genetic, and clinical factors”. Clin Exp Gastroenterol. 5: 113–21. doi:10.2147/CEG.S32368. PMC 3401057. PMID 22826639.
  4. Mattar R, de Campos Mazo DF, Carrilho FJ (2012). “Lactose intolerance: diagnosis, genetic, and clinical factors”. Clin Exp Gastroenterol. 5: 113–21. doi:10.2147/CEG.S32368. PMC 3401057. PMID 22826639.
  5. Silanikove N, Leitner G, Merin U (2015). “The Interrelationships between Lactose Intolerance and the Modern Dairy Industry: Global Perspectives in Evolutional and Historical Backgrounds”. Nutrients. 7 (9): 7312–31. doi:10.3390/nu7095340. PMC 4586535. PMID 26404364.
  6. Thorning TK, Raben A, Tholstrup T, Soedamah-Muthu SS, Givens I, Astrup A (2016). “Milk and dairy products: good or bad for human health? An assessment of the totality of scientific evidence”. Food Nutr Res. 60: 32527. PMC 5122229. PMID 27882862.

Template:WH Template:WS

Diagnosis

Diagnosis

Diagnostic Study of Choice |History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case Studies

Case #1

Related Chapters
External Links


Template:Gastroenterology Template:Endocrine, nutritional and metabolic pathology bg:Лактозна толерантност de:Laktoseintoleranz id:Lactose intolerance is:Mjólkuróþol he:רגישות ללקטוז nl:Lactose-intolerantie no:Laktoseintoleranse fi:Laktoosi-intoleranssi sv:Laktosintolerans uk:Непереносимість лактози


Template:WikiDoc Sources

[[Category:Endocrinology

Looking for the patient version?

Back to the patient-friendly article

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH